Telomir Pharmaceuticals (TELO) Shares Issued (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Shares Issued of $4.2 million for Q4 2025, little changed sequentially from $4.2 million in Q3 2025, and up 78.0% YoY from $2.4 million in Q4 2024.
Telomir Pharmaceuticals (TELO) Shares Issued (2023 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Shares Issued for 3 years, with the latest figure at $4.2 million in Q4 2025.
- Quarterly Shares Issued rose 78.0% year-over-year to $4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 78.0% YoY) and the FY2025 annual result came in at $4.2 million, up 78.0% from the prior year.
- Shares Issued held at $4.2 million in Q4 2025 per TELO's latest filing, from $4.2 million in the prior quarter.
- Over five years, Shares Issued peaked at $4.2 million in Q2 2025 and troughed at $2.3 million in Q1 2025.
- A 3-year average of $3.2 million and a median of $2.8 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued dropped 16.4% in 2024, then surged 78.0% in 2025.
- Over 3 years, Shares Issued stood at $2.8 million in 2023, then decreased by 16.4% to $2.4 million in 2024, then jumped by 78.0% to $4.2 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $4.2 million, $4.2 million, and $4.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Telomir Pharmaceuticals | 68.14 Mn | 68.14 Mn | - | 400.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 4.19 Mn |
| Sep 30, 2025 | 4.19 Mn |
| Jun 30, 2025 | 4.24 Mn |
| Jun 30, 2025 | 4.24 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.81 Mn |
| Dec 31, 2023 | 2.81 Mn |